150 related articles for article (PubMed ID: 15564451)
41. A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein.
Byland R; Vance PJ; Hoxie JA; Marsh M
Mol Biol Cell; 2007 Feb; 18(2):414-25. PubMed ID: 17108326
[TBL] [Abstract][Full Text] [Related]
42. Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope.
Doria-Rose NA; Learn GH; Rodrigo AG; Nickle DC; Li F; Mahalanabis M; Hensel MT; McLaughlin S; Edmonson PF; Montefiori D; Barnett SW; Haigwood NL; Mullins JI
J Virol; 2005 Sep; 79(17):11214-24. PubMed ID: 16103173
[TBL] [Abstract][Full Text] [Related]
43. Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging.
Poon DT; Coren LV; Ott DE
J Virol; 2000 Apr; 74(8):3918-23. PubMed ID: 10729169
[TBL] [Abstract][Full Text] [Related]
44. The Rous sarcoma virus Env glycoprotein contains a highly conserved motif homologous to tyrosine-based endocytosis signals and displays an unusual internalization phenotype.
Ochsenbauer C; Dubay SR; Hunter E
Mol Cell Biol; 2000 Jan; 20(1):249-60. PubMed ID: 10594028
[TBL] [Abstract][Full Text] [Related]
45. Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein.
Emerson V; Holtkotte D; Pfeiffer T; Wang IH; Schnölzer M; Kempf T; Bosch V
J Virol; 2010 Feb; 84(3):1355-65. PubMed ID: 19906925
[TBL] [Abstract][Full Text] [Related]
46. Identification of a novel splice acceptor in the HIV-1 genome: independent expression of the cytoplasmic tail of the envelope protein.
Berkhout B; van Wamel JL
Arch Virol; 1996; 141(5):839-55. PubMed ID: 8678830
[TBL] [Abstract][Full Text] [Related]
47. Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein.
Lodge R; Delamarre L; Lalonde JP; Alvarado J; Sanders DA; Dokhélar MC; Cohen EA; Lemay G
J Virol; 1997 Jul; 71(7):5696-702. PubMed ID: 9188652
[TBL] [Abstract][Full Text] [Related]
48. Tryptophan-based motifs in the LLP3 region of the HIV-1 envelope glycoprotein cytoplasmic tail direct trafficking to the endosomal recycling compartment and mediate particle incorporation.
Lerner G; Ding L; Spearman P
J Virol; 2023 Oct; 97(10):e0063123. PubMed ID: 37796124
[TBL] [Abstract][Full Text] [Related]
49. A natural antisense RNA derived from the HIV-1 env gene encodes a protein which is recognized by circulating antibodies of HIV+ individuals.
Vanhée-Brossollet C; Thoreau H; Serpente N; D'Auriol L; Lévy JP; Vaquero C
Virology; 1995 Jan; 206(1):196-202. PubMed ID: 7831774
[TBL] [Abstract][Full Text] [Related]
50. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.
Earl PL; Hügin AW; Moss B
J Virol; 1990 May; 64(5):2448-51. PubMed ID: 2182912
[TBL] [Abstract][Full Text] [Related]
51. Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.
Bour SP; Aberham C; Perrin C; Strebel K
J Virol; 1999 Jan; 73(1):778-82. PubMed ID: 9847387
[TBL] [Abstract][Full Text] [Related]
52. Validation of HIV-1 MA Shell Structural Arrangements and Env Protein Interactions Predict a Role of the MA Shell in Viral Maturation.
Mangukia TA; Santos JRL; Sun W; Cesarz D; Ortíz Hidalgo CD; Marcet-Palacios M
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112873
[TBL] [Abstract][Full Text] [Related]
53. Analysis of HIV-1 envelope cytoplasmic tail effects on viral replication.
Alfadhli A; Romanaggi C; Barklis RL; Barklis E
Virology; 2023 Feb; 579():54-66. PubMed ID: 36603533
[TBL] [Abstract][Full Text] [Related]
54. Changes in ds/dn in the HIV-1 env gene.
Nielsen R
Mol Biol Evol; 1999 May; 16(5):711-4. PubMed ID: 10335663
[No Abstract] [Full Text] [Related]
55. Corrigendum: HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity.
Serena M; Parolini F; Biswas P; Sironi F; Blanco Miranda A; Zoratti E; Scupoli MT; Ziglio S; Valenzuela-Fernandez A; Gibellini D; Romanelli MG; Siccardi A; Malnati M; Beretta A; Zipeto D
Sci Rep; 2018 May; 8():46991. PubMed ID: 29786690
[TBL] [Abstract][Full Text] [Related]
56. Intracellular immunization: Expression of antibody domains in the cytoplasm and in the nucleus of mammalian cells.
Biocca S; Di Luzio A; Werge T; Cattaneo A
Cytotechnology; 1991 Feb; 5(Suppl 1):49-50. PubMed ID: 22358952
[No Abstract] [Full Text] [Related]
57. Antigen-display exosomes provide adjuvant-free protection against SARS-CoV-2 disease at nanogram levels of spike protein.
Guo C; Sachithanandham J; Zhong W; Craney M; Villano J; Pekosz A; Gould SJ
bioRxiv; 2024 Jan; ():. PubMed ID: 38328234
[TBL] [Abstract][Full Text] [Related]
58. Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14
Hoffman HK; Aguilar RS; Clark AR; Groves NS; Pezeshkian N; Bruns MM; van Engelenburg SB
J Virol; 2022 Jul; 96(14):e0076722. PubMed ID: 35770989
[TBL] [Abstract][Full Text] [Related]
59. Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.
Zhang S; Nguyen HT; Ding H; Wang J; Zou S; Liu L; Guha D; Gabuzda D; Ho DD; Kappes JC; Sodroski J
J Virol; 2021 Jan; 95(3):. PubMed ID: 33148792
[TBL] [Abstract][Full Text] [Related]
60. The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization.
Salimi H; Johnson J; Flores MG; Zhang MS; O'Malley Y; Houtman JC; Schlievert PM; Haim H
J Biol Chem; 2020 Jan; 295(2):348-362. PubMed ID: 31757809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
